Sean Sullivan

Sean Sullivan

Company: Arcturus Therapeutics

Job title: Executive Director


Immunogenicity Characterization of mRNA Vaccines 2:30 pm

Preliminary preclinical results for second generation vaccines designed with improved anti-viral immunogenicity exhibited cross neutralization against alpha, beta, gamma and delta circulating viral variants in mice and non-human primates Rhesus macaque immunogenicity studies showed high neutralizing antibody titers after two prime injections 28 days apart. A further increase in neutralizing antibody titers were observed with…Read more

day: Pre-Conference Focus Day: Deep Dive into mRNA Characterization & Discovery

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.